Working… Menu
Trial record 31 of 45 for:    colon cancer | ( Map: Hawaii, United States )

Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00063141
Recruitment Status : Completed
First Posted : June 25, 2003
Last Update Posted : April 12, 2010
Bristol-Myers Squibb
Information provided by:
ImClone LLC

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 2006
Actual Study Completion Date : October 2007